HaberbergerRL,
FoxE,
AsselinP,
Said-SalahY,
MartinezS,
AbbatteEA.
Is Djibouti too hot and too humid for meningococci?. Trans R Soc Trop MedHyg1990; 84:588
VirjiM,
AlexandrescuC,
FergusonDJP,
SaundersJR,
MoxonER.
Variations in the expression of pili, the effect on adherence of Neisseria meningitidis in human epithelial and endothelial cells. Mol Microbiol1992; 6:1271–1279
PerryACF,
HartCA,
NicolsonIJ,
HeckelsJE,
SaundersJA.
Inter strain homology of pilin gene sequences in Neisseria meningitidis isolates that express markedly different antigenic pilus types. J Gen Microbiol1987; 133:1409–1418
FoxAJ,
JonesDM,
GrayJJ,
CaugantDA,
SaundersNA.
An epidemiologically valuable typing method for Neisseria meningitidis by analysis of restriction fragment length polymorphisms. J Med Microbiol1991; 34:265–270
OlyhoekT,
CroweBA,
AchtmanM.
Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev Infect Dis1987; 9:665–692
LiX,
HuX,
GaoL,
XiW,
JiY,
HuZ.
The clonal population structure and serosubtypes of Neisseria meningitidis serogroup A isolated in China. In:
AchtmanM,
KohlP,
MarchalC,
MorelliG,
SeilerA,
ThiesenB.
(eds) Neisseriae—1990 Berlin: Walter de Gruyter and Co.; 1991159
WedegeE,
CaugantDA,
FroholmLO,
ZollingerWD.
Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis. J Clin Microbiol1991; 29:1486–1492
WangJ-F,
CaugantDA,
LiX et al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in China. Infect Immun1992; 60:5267–5282
MorelliG,
LammelCJ,
PohlerJ et al. Immunogenicity and variability of epitopes within the IgAl pro tease from serogroup A Neisseria meningitidis. Mol Microbiol1993 (in preparation)
SukerJ,
AchtmanM,
WangJ-F,
FeaversIM,
MaidenMCJ.
The class 1 outer membrane protein (OMP) of serogroup A meningococci: Epidemiological inferences from nucleotide sequence data. In: Proceedings of the Eighth International Pathogenic Neisseria Conference1993 in press
CroweBA,
WallRA,
KusecekB et al. Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in the Gambia, West Africa. J Infect Dis1989; 159:686–700
SalihMAM,
DanielssonD,
BackmanA,
CaugantDA,
AchtmanM,
OlcenP.
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol1990; 28:1711–1719
BjorvatnB,
Hassan-KingM,
GreenwoodB,
HaimanotRT,
FekadeD,
SperberG.
DNA fingerprinting in the epidemiology of African serogroup A Neisseria meningitidis. Scand J Infect Dis1992; 24:323–332
AchtmanM,
NeibertM,
CroweBA et al. Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med1988; 168:507–525
AchtmanM,
KusecekB,
MorelliG et al. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis1992; 65:53–68
MeyerTF,
van PuttenJPM.
Genetic mechanisms and biological implications of phase variation in pathogenic Neisseriae. Clin Microbiol Rev1989; 2:Suppl:S139–S145
OlyhoekAJM,
SarkariJ,
BoppM,
MorelliG,
AchtmanM.
Cloning and expression in Escherichia coli of opc, the gene for an unusual class 5 outer membrane protein from Neisseria meningitidis. Microb Pat hog1991; 11:249–257
AchtmanM,
WallRA,
BoppM et al. Variation in class 5 protein expression by serogroup A meningococci during a meningitis epidemic. J Infect Dis1991; 164:375–382
AhoEL,
DempseyJA,
HobbsMM,
KlapperDG,
CannonJG.
Characterization of the opa (class 5) gene family of Neisseria meningitidis. Mol Microbiol1991; 5:14291437
SarkariJF,
OlyhoekT,
BoppM et al. Class 5 proteins and opa genes in clones IV-1 and III-l of Neisseria meningitidis serogroup A. In:
AchtmanM,
KohlP,
MarchalC,
MorelliG,
SeilerA,
TheisenB.
(eds) Neisseriae-1990 Berlin: Walter de Gruyter and Co.; 1991539
VirjiM,
MakepeaceK,
FergusonDJP,
AchtmanM,
SarkariJ,
MoxonER.
Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol Microbiol1992; 6:2785–2795
RosenqvistE,
HoibyEA,
WedegeE,
KusecekB,
AchtmanM.
The 5c protein of Neisseria meningitidis is highly immunogenic in humans and stimulates bactericidal antibodies. J Infect Dis 1993: in press
de CossioMEF,
OhlinM,
LlanoM et al. Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis. J Infect Dis1992; 166:1322–1328
WangJ-F,
MorelliG,
BoppM et al. Clonal and antigenic analyses of Neisseria meningitidis bacteria belonging to the ET37 complex isolated from Mali and elsewhere. In:
AchtmanM,
KohlP,
MarchalC,
MorelliG,
SeilerA,
ThiesenB.
(eds) Neisseriae—1990 Berlin: Walter de Gruyter and Co.; 1991141
WangJ-F,
CaugantDA,
MorelliG,
KoumareB,
AchtmanM.
Antigenic and epidemiological properties of the ET37 complex of Neisseria meningitidis. J Infect Dis1993 (in press)
GotschlichEC,
LiuT-Y,
ArtensteinMS.
Human immunity to the meningococcus III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med1969; 129:1349–1365
ConnellTD,
ShafferD,
CannonJG.
Characterization of the repertoire of hypervariable regions in the protein-II (opa) gene family of Neisseria gonorrhoeae. Mol Microbiol1990; 4:439–449
ConnellTD,
BlackWJ,
KawulaTH et al. Recombination among protein-II genes of Neisseria gonorrhoeae generates new coding sequences and increases structural variability in the protein-II family. Mol Microbiol1988; 2:227–236
StephensDS,
WhitneyAM,
RothbardJ,
SchoolnikGK.
Pili of Neisseria meningitidis—analysis of structure and investigation of structural and antigenic relationships to gonococcal pili. J Exp Med1985; 161:1539–1553
TinsleyCR,
HeckelsJE.
Variation in the expression of pili and outer-membrane protein by Neisseria meningitidis during the course of meningococcal infection. J Gen Microbiol1986; 132:2483–2490
StephensDS,
KrebsJW,
McGeeZA.
Loss of pili and decreased attachment to human-cells by Neisseria meningitidis and Neisseria gonorrhoeae exposed to subinhibitory concentrations of antibiotics. Infect Immun1984; 46:507–513
StephensS,
ZollingerWD,
SchoolnikGK.
Pathogenesis of Neisseria meningitidis—effect of pili and pilin sub-unit antibodies on adherence of meningococci to human-cells. Clin Res1983; 31:22–23
StephensDS,
HoffmanLH,
McGeeZA.
Interaction of Neisseria meningitidis with human nasopharyngeal mucosa—attachment and entry into columnar epithelial-cells. J Infect Dis1983; 148:369–376
StephensDS,
McGeeZA.
Attachment of Neisseria meningitidis to human mucosal surfaces—influence of pili and type of receptor cell. J Infect Dis1981; 143:525–532
VirjiM,
KayhtyH,
FergusonDJP,
AlexandrescuC,
HeckelsJE,
MoxonER.
The role of pili in the interactions of pathogenic neisseria with cultured human endothelial-cells. Mol Microbiol1991; 5:1831–1841
VirjiM,
HeckelsJE,
PottsWJ,
HartCA,
SaundersJR.
Identification of epitopes recognized by monoclonal-anti- bodies SMI and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between 2 structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp. J Gen Microbiol1989; 135:3239–3251
PottsWJ,
SaundersJR.
Nucleotide-sequence of the structural gene for class-I pilin from Neisseria meningitidis—homologies with the pilE locus of Neisseria gonorrhoeae. Mol Microbiol1988; 2:647–653
VirjiM,
HeckelsJE.
Role of anti-pilus antibodies in host defense against gonococcal-infection studied with monoclonal anti-pilus antibodies. Infect Immun1985; 49:621628
VirjiM,
HeckelsJE.
The role of common and type-specific pilus antigenic domains in adhesion and virulence of gonococci for human epithelial cells. J Gen Microbiol1984; 130:1089–1095
VirjiM,
HeckelsJE.
Antigenic cross-reactivity of neisseriapili—investigations with type-specific and species-specific monoclonal antibodies. J Gen Microbiol1983; 129:2761–2768
RothbardJB,
SchoolnikGK.
The primary sequence and antigenic structure of gonococcal pilin—approaches towards a gonococcal vaccine. Adv Exp Med Biol1985; 185:247–273
ZakK,
DiazJL,
JacksonD,
HeckelsJE.
Antigenic variation during infection with Neisseria gonorrhoeae—detection of antibodies to surface-proteins in sera of patients with gonorrhea. J Infect Dis1984; 149:166–174
VirjiM,
HeckelsJE.
Location of a blocking epitope on outer-membrane protein-III of Neisseria gonorrhoeae by synthetic peptide analysis. J Gen Microbiol1989; 135:1895–1899
HaasR,
VeitS,
MeyerTF.
Silent pilin genes of Neisseria gonorrhoeae MS11 and the occurrence of related hypervariant sequences among other gonococcal isolates. Mol Microbiol1992; 6:197–208
TahaMK,
SoM,
SeifertHS,
BillyardE,
MarchalC.
Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control. EM BO J1988; 7:4367–4378
TahaMK,
DupuyB,
SaurinW,
SoM,
MarchalC.
Control of pilus expression in Neisseria gonorrhoeae as an original system in the family of 2-component regulators. Mol Microbiol1991; 5:137–148
RossSC,
DensenP.
Complement deficiency states and infection. Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine1984; 63:243–273
BrandtzaegP,
KierulfP,
GaustadP et al. Plasma endotoxin as predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis1989; 159:195–204
WaageA,
BrandtzaegP,
HalstensenA et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med1989; 169:333–338
JacobCJ,
FronekZ,
LewisGD et al. Heritable major histocompatibility complex class II associated differences in production of tumour necrosis factor X: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA1990; 87:1233–1237
KayhtyH,
Jousimies-SomerH,
PettolaH,
MakelaPH.
Anti body response to capsular polysaccharides of Group A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteraemic disease. J Infect Dis1981; 143:32–41
AmbrosinoDM,
SiberGR,
ChilmonczykBA et al. An immunodeficiency characterised by impaired antibody responses to polysaccharides. N Engl J Med1987; 316:790–793
GriffissJM,
BrandtBI,
BroudDD et al. Immune response in infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis1984; 150:71–79
HoffmanTA,
EdwardsEA.
Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis. J Infect Dis1972; 126:636–644
SiberGR,
SchurPH,
AisenbergAC et al. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med1980; 267:302–303
SchlesingerY,
GranoffDM.
Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae Type b conjugate vaccines. J Am Med Assoc1992; 267:1489–1494
HarthugS,
RosenqvistE,
HoibyEA et al. Antibody response in Group B meningococcal disease determined by enzyme- linked immunosorbent assay with serotype 15 outer membrane antigen. J Clin Microbiol1986; 24:947–953
RosenqvistE,
HarthugS,
FroholmLO et al. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection. J Clin Microbiol1988; 26:1543–1548
MaelandJA,
WedegeE.
Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease. APMIS1989; 97:774–780
BundellKR,
FoxAJ,
GuiverM et al. The development of an inhibition enzyme-linked immunosorbent assay to detect total antibody to the PI. 16 subtype antigen of Neisseria meningitidis in human sera. Serodiagn Immunother1987; 1:353–361
EstabrookMM,
MandrellRE,
ApicellaMA,
GriffissJM.
Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide. Infect Immun1990; 58:2204–2213
ZollingerWD,
MandrellRE.
Studies of the human antibody response to specific meningococcal outer membrane proteins of serotype 2 and 15. Med Trop1983; 43:143–147
BlackJR,
BlackWJ,
CannonJG.
Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. J Infect Dis1985; 151:650–657
BlackJR,
DyerDW,
ThompsonMK,
SparlingPF.
Human immune response to iron repressible outer membrane proteins of Neisseria meningitidis. Infect Immun1986; 54:710–713
Ala’AldeenDA,
WallRA,
BorrielloSP.
Immunogenicity and cross reactivity of the 70-Kda iron regulated protein of Neisseria meningitidis in man and animals. J Med Microbiol1990; 32:275–281
RossSC,
RosenthalPJ,
BerberichHM,
DensenP.
Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement-deficient individuals. J Infect Dis1987; 155:1266–1275
LowellGH,
SmithLF,
ArtensteinMS et al. Antibody dependent cell mediated antibacterial activity of human mononuclear cells. 1. K-Lymphocytes and monocytes are effective against meningococci in co-operation with human immune sera. J Exp Med1979; 150:127–137
OrrenA,
WarrenRE,
PotterPC et al. Antibodies to Meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects. Infect Immun1992; 60:4510–4516
KarrulaTH,
AhoEL,
BarrittDS et al. Reversible phase variation of expression of Neisseria meningitidis class 5 outer membrane proteins and their relationship to gonococcal proteins II. Infect Immun1988; 56:380–386
PoolmanJT,
TimmermansHAM,
HopmanCTP et al. Comparison of meningococcal outer membrane protein vaccines solubilised with detergent or C polysaccharide. In: Gonococci and meningococciProceedings of 5th International Pathogenic Neisseriae Conference Dordrecht: Kluver Academic Publishers; 1988159–165
van PuttenJPM,
LindersMTJ,
WeelJFL,
PoolmanJT.
Differential expression of Fe-repressible and growth rate sensitive proteins in Neisseria meningitidis and Neisseria gonorrhoeae. In: Gonococci and meningococciProceedings of 5th International Pathogenic Neisseriae Conference Dordrecht: Kluver Academic Publishers; 1988781–788
KeevilCW,
MajorNC,
DaviesDB,
RobinsonA.
Physiology and virulence determinants of Neisseria gonorrhoeae grown in glucose, oxygen or cystine-limited continuous culture. J Gen Microbiol1986; 132:3289–3302
WallRA,
DaviesHA,
BorrielloSP.
Epitopes of serogroup B Neisseria meningitidis analysed in vitro and directly from cerebrospinal fluid. FEMS Microbiol Lett1989; 65:129–136
GreenwoodBM,
GreenwoodAM,
BradleyAK et al. Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. J Infect1987; 14:167–184
GriffissJM,
BertramMA.
Immunoepidemiology of menin-gococcal disease in military recruits—II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J Infect Dis1977; 136:733–739
MunkleyA,
TinsleyCR,
VirjiM,
HeckelsJE.
Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb Pathog1991; 11:447–452
MarzoukO,
ThomsonAPJ,
SillsJA,
HartCA.
Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child1991; 66:485–487
Gedde-DahlTW,
BjarkP,
HoibyEA,
HostJH,
BruunJN.
Severity of meningococcal disease: assessment by factors and scores and implications for patient management. Rev Infect Dis1990; 12:973–992
LeclercF,
ChenandM,
DelepoulleF,
DiependaeleJF,
MartinotA,
HueV.
Prognostic value of C-reactive protein level in severe infectious purpura: a comparison with eight other scores. Crit Care Med1991; 19:430–432
StoklandT,
FlaegstadT,
GuttebergTJ.
A clinical score for the prediction of outcome of patients with meningococcal infection. Acta Paediatr Scand1985; 322:S12
ThomsonAPJ,
SillsJA,
HartCA.
Validation of the Glasgow Meningococcal Septicaemia Prognostic Score: a 10-year retrospective survey. Crit Care Med1991; 19:26–30
ReingoldAC,
BroomeCV,
HightowerAW et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet1985; 2:114–118
SierraGVG,
CampaHC,
VaracelNM et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann1991; 14:195–210
BjuneG,
HoibyEA,
GronnesbyJK et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet1991; 338:1093–1096
BlakebroughIS,
GreenwoodBM,
WhittleHC,
BradleyAK,
GillesHM.
Failure of meningococcal vaccination to stop transmission of meningococci in Nigerian schoolboys. Ann Trop Med Parasitol1983; 77:175–178
The Meningococcal Disease Surveillance Group Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis1976; 134:201–204
De WalsP,
HertogheL,
Borlee-GrimeeI et al. Meningococcal disease in Belgium, secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect1981; 3:Suppl 153–61
CookeRPD,
RiordanT,
JonesDM,
PainterMJ.
Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. BMJ1989; 298:555–558
KuhnsDW,
NelsonCT,
FeldmanHA,
KuhnsLR.
The prophylactic value of sulfadiazine in the control of meningococcic meningitis. J Am Med Assoc1943; 123:335–339
MunfordRS,
SussuramaZJ,
PhillipsCJ et al. Eradication of carriage of Neisseria meningitidis in families: a study from Brazil. J Infect Dis1974; 129:644–649
DrewTM,
AltmanR,
BlackK,
GoldfieldM.
Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients. J Infect Dis1976; 133:194–198
KaiserAB,
HennekensCH,
SaslowMS et al. Seroepidemiology and chemoprophylaxis of disease due to sulphona-mide-resistant Neisseria meningitidis in a civilian population. J Infect Dis1974; 130:217–224
HartCA,
CuevasLE,
KazembeP,
MughoghoGK,
TillotsonGS.
The use of ciprofloxacin to eradicate oropharyngeal carriage of Neisseria meningitidis '. A preliminary analysis. Adv Antimicrob Antineopl Chemother1992; 11:167–171
SchubigerG,
MunzinJ,
DudliC,
WipfliU.
Meningokokken-epidemic in einer internatsschule Sekundererkrangkung mit Rifampicin-resistentem Erreger unter Chemopro- phylaxe. Schweiz Med Wochenschr1986; 116:1172–1175
SchwartzB,
Al-TobaiqiA,
Al-RuwaisA et al. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of Group A Neisseria meningitidis. Lancet1988; 1:1239–1242
GauntPN,
LambertBE.
Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother1988; 21:489–496
DworzackDL,
SandersCC,
HorowitzEA et al. Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother1988; 32:1740–1741
PugsleyMP,
DworzackDL,
RoccaforteJS et al. An open study of the efficacy of a single dose of ciprofloxacin in eliminating the chronic nasopharyngeal carriage of Neisseria meningitidis. J Infect Dis1988; 157:852–853
HudsonPJ,
VogtRL,
HeunEM et al. Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis1986; 5:213–217
StuartJM,
CartwrightKAV,
RobinsonPM,
NoahND.
Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?. BMJ1989; 298:569–570
FraschCE,
ZollingerWD,
PoolmanJT.
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis1985; 7:504–510
ZollingerW,
BoslegoJ,
MoranEE,
BrandtBL,
CruzC,
MartinezM.
Effect of vaccination with meningococcal OMP vaccine on subsequent antibody response to natural infections. Proceedings of the Eighth International Pathogenic Neisseria ConferenceConde-GlezGM et al.
(eds), in press
Banerjee-BhatnagarN,
FraschCE.
Expression of Neisseria meningitidis iron-regulated outer-membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines. Infect Immun1990; 58:2875–2881
van der LeyP,
PoolmanJT.
Construction of a multivalent meningococcal vaccine strain based on the class-1 outer-membrane protein. Infect Immun1992; 60:3156–3161
DeviSJN,
RobbinsJB,
SchneersonS.
Antibodies to poly[(2-]8)-alpha-n-acetylneuraminic acid] and poly [(2—]9)-alpha-n-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli k92 conjugates: potential vaccines for group-B and group-C meningococci and Escherichia coli kl. Proc Natl Acad Sci USA1991; 88:7175–7179
SaukkonenK,
LeinonenM,
AbdillahiH,
PoolmanJT.
Comparative evaluation of potential components for group-B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine1989; 7:325–328
BarlowAK,
HeckelsJE,
ClarkeIN.
Molecular-cloning and expression of Neisseria meningitidis class-1 outer-mem- brane protein in Escherichia coli k-12. Infect Immun1987; 55:2734–2740
McGuinnessBT,
LambdenPR,
HeckelsJE.
Class 1 outer membrane protein of Neisseria meningitidis: Epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 1993: in press
ChristodoulidesM,
McGuinnessBT,
HeckelsJE.
Immu nisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis '. production of bactericidal antibodies on immunisation with a cyclic peptide; 1992 (unpublished observations)
VerheulAFM,
BoonsGJPH,
VandermarelGA et al. Minimal oligosaccharide structures required for induction of im-mune-responses against meningococcal immunotype 11, 12, and 13, 7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates. Infect Immun1991; 59:3566–3573
BoonsGJPH,
HoogerhoutP,
PoolmanJT,
Van der MarelGA,
Van BoomJH.
Preparation of a well-defined sugar-peptide conjugate—a possible approach to a synthetic vaccine against Neisseria meningitidis. Bioorg Medic Chem Lett1991; 1:303–308
PetterssonA,
KuipersB,
PelzerM et al. Monoclonal-antibodies against the 70-kilodalton iron-regulation protein of Neisseria meningitidis are bactericidal and strain specific. Infect Immun1990; 58:3036–3041
GriffithsE,
StevensonP,
RayA.
Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis. FEMS Microbiol Lett1990; 69:31–36
RokbiB,
MazarinV,
MaitreG,
DupuyM,
Quentin-MilletMJ.
Molecular mass heterogeneity, antigenic and genomic variability of transferrin binding proteins among Neisseria meningitidis strains. In: Proceedings of the Eighth International Pathogenic Neisseria ConferenceConde-GlezGM et al.
(eds), in press